Medications

Disputed asthma drugs have safe record in British Columbia

A popular combination asthma therapy dogged by safety concerns has not harmed British Columbians and should remain in use, according to researchers at the University of British Columbia and Vancouver Coastal Health Research ...

Inflammatory disorders

Hope of new treatment for severe asthma patients

New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...

Medications

Asthma medicines a struggle for many countries

(Medical Xpress)—The availability, pricing and affordability of three essential asthma medicines varies greatly according to a new study of 52 low-and middle-income countries

Diseases, Conditions, Syndromes

Inhaled corticosteroids raise pneumonia risk

A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection.

Diseases, Conditions, Syndromes

Fungal infections can trigger and exacerbate asthma

(Medical Xpress)—A common fungal infection can trigger asthma and make it much worse by way of a route not targeted by existing asthma drugs, report researchers at Boston Children's Hospital. Their findings, published online ...

Diseases, Conditions, Syndromes

Single combo inhaler beats standard rx in asthma

(HealthDay)—Maintenance and reliever therapy with a single inhaled corticosteroid plus a rapid-onset, long-acting, β2 agonist (formoterol) seems beneficial for patients with asthma, according to two studies published in ...

Diseases, Conditions, Syndromes

Cost of medication and stigma leading asthma sufferers to risk health

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ ...

Medications

Added benefit of aclidinium bromide is not proven

The drug aclidinium bromide (trade names Eklira, Bretaris) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality ...

page 3 from 5